Clinton Yam

8PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 13, 2026
Ecotypes of triple-negative breast cancer in response to chemotherapy.

|May 04, 2026
Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase) Inhibitors: A Single-Institution Experience.

|Jan 21, 2026
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

Sara M Tolaney, Evandro de Azambuja, Kevin Kalinsky

|Nov 20, 2025
Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer.

Mary S Guirguis, Beatriz E Adrada, Clinton Yam

|Aug 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.

Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai

|Dec 31, 2024
NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression.

Tejaswini Reddy, Akshjot Puri, Liliana Guzman-Rojas

Pageof 2

Frequent Collaborators

4 joint publications

Debu Tripathy

3 joint publications

Stacy L Moulder

3 joint publications

Jeffrey T Chang

3 joint publications

Lei Huo